Engineering BCMA-CAR T cells to overcome CD19-negative relapse in B cell non-Hodgkin lymphomas

被引:0
|
作者
Antonana-Vildosola, A. [1 ]
Perez-Amill, L. [1 ]
Sune, G. [1 ]
Castella, M. [1 ]
Najjar, A. [2 ]
Urbano, A. [1 ,3 ]
Martin-Antonio, B. [1 ,3 ]
机构
[1] IDIBAPS, Barcelona, Spain
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Josep Carreras Leukemia Res Inst, Barcelona, Spain
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P164
引用
收藏
页码:A67 / A68
页数:2
相关论文
共 50 条
  • [41] Exploratory study on the efficacy of bortezomib combining mitoxantrone or CD22-CAR T therapy targeting CD19-negative relapse after CD19-CAR T cell therapy with a simpler cell-line-based model
    Ba, Diandian
    Li, Hongzhe
    Liu, Rongrong
    Zhang, Ping
    Tang, Yongmin
    APOPTOSIS, 2023, 28 (11-12) : 1534 - 1545
  • [42] Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas
    Johnson, P. Connor
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2561 - 2567
  • [43] Chimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas
    Levin, Adam
    Shah, Nirav N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S18 - S23
  • [44] Chimeric T-Cells for Therapy of CD30+Hodgkin and Non-Hodgkin Lymphomas (HL & NHL)
    Ramos, Carlos A.
    Ballard, Brandon
    Liu, Enli
    Dakhova, Olga
    Mei, Zhuyong
    Liu, Hao
    Grilley, Bambi
    Rooney, Cliona M.
    Gee, Adrian P.
    Chang, Bill H.
    Bollard, Catherine M.
    Brenner, Malcolm K.
    Dotti, Gianpietro
    Heslop, Helen E.
    Savoldo, Barbara
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S145 - S146
  • [45] A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    Zhang, Ying
    Li, Jiaqi
    Lou, Xiaoyan
    Chen, Xiaochen
    Yu, Zhou
    Kang, Liqing
    Chen, Jia
    Zhou, Jin
    Zong, Xiangping
    Yang, Zhen
    Li, Minghao
    Xu, Nan
    Jia, Sixun
    Geng, Hongzhi
    Chen, Guanghua
    Dai, Haiping
    Tang, Xiaowen
    Yu, Lei
    Wu, Depei
    Li, Caixia
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy
    Guo, Shanshan
    Lei, Wen
    Jin, Xueli
    Liu, Hui
    Wang, James Q.
    Deng, Wenhai
    Qian, Wenbin
    BLOOD ADVANCES, 2024, 8 (11) : 2635 - 2645
  • [47] Interleukin-18 Secreting Autologous Anti-CD19 CAR T-Cells (huCART19-IL18) in Patients with Non-Hodgkin Lymphomas Relapsed or Refractory to Prior CAR T-Cell Therapy
    Svoboda, Jakub
    Gerson, James N.
    Landsburg, Daniel J.
    Chong, Elise A.
    Barta, Stefan K.
    Nasta, Sunita Dwivedy
    Ruella, Marco
    Hexner, Elizabeth O.
    Marshall, Amy
    Leskowitz, Rachel
    Four, Megan
    Shea, Joanne
    Matlawski, Tina
    Cervini, Amanda
    Davis, Megan M.
    Gohil, Mercy
    Scholler, John
    Hasenmayer, Donald
    Amortegui, Juliana Rojas
    Brennan, Andrea
    Plesa, Gabriela
    Hwang, Wei-Ting
    Porter, David L.
    Fraietta, Joseph
    Schuster, Stephen J.
    June, Carl H.
    BLOOD, 2022, 140 : 4612 - 4614
  • [48] Anti CD19 CAR-T Cell Therapy Can Clear Minimal Residual Disease in Bone Marrow of Patients with Relapsed or Refractory B Cell Non-Hodgkin's Lymphomas
    Dhaliwal, Armaan
    Zandu, Mahima
    Khurana, Sharad
    Kumar, Abhijeet
    Pu, Jeffrey J.
    Katsanis, Emmanuel
    Husnain, Muhammad
    BLOOD, 2022, 140 : 12760 - 12761
  • [49] Establishment of CD19-CAR-T Cell Production and Treatment of Non-Hodgkin Lymphoma in the United Arab Emirates
    Abu Haleeqa, Mohamed I.
    El-Najjar, Inas
    Afifi, Yara K.
    Ali, Sheima A.
    Alsaadawi, Nameer
    Dennison, Jayakumar David
    Sachdev, Mansi
    Obeidat, Sakher A.
    Aleman, Yandy Marx Castillo
    Handgretinger, Rupert
    Ibrahim, Asia
    Wahdan, Rasha
    al Kaabi, Fatema
    Ventura-Carmenate, Yendry
    Hadi, Loubna A.
    Hernandez-Ramirez, Antonio
    Al Karam, Maysoon
    BLOOD, 2024, 144 : 7268 - 7269
  • [50] Glycolytic activity following anti-CD19 CAR-T cell infusion in non-Hodgkin lymphoma
    Vallet, Nicolas
    Larochelle, Laurianne Drieu
    Santiago-Ribeiro, Maria-Joao
    Villate, Alban
    Eloit, Martin
    Ciree, Arnaud
    Zaragoza, Laura
    Andre, Virginie
    Prat-Lepesant, Marie
    Herault, Olivier
    Arbion, Flavie
    Blasco, Helene
    Gyan, Emmanuel
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025, 55 (02)